e-learning
resources
Virtual 2020
Pre-Congress Content
Respiratory viruses in the "pre COVID-19" era
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
CURRENT MANAGEMENT OF ACUTE BRONCHIOLITIS IN SWITZERLAND
K. Hartog (St. Gallen, Switzerland), C. Ardura-Garcia (Bern , Switzerland), J. Hammer (Basel , Switzerland), C. Kuehni (Bern, Switzerland), J. Barben (St. Gallen , Switzerland)
Source:
Virtual Congress 2020 – Respiratory viruses in the "pre COVID-19" era
Session:
Respiratory viruses in the "pre COVID-19" era
Session type:
E-poster session
Number:
2382
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Hartog (St. Gallen, Switzerland), C. Ardura-Garcia (Bern , Switzerland), J. Hammer (Basel , Switzerland), C. Kuehni (Bern, Switzerland), J. Barben (St. Gallen , Switzerland). CURRENT MANAGEMENT OF ACUTE BRONCHIOLITIS IN SWITZERLAND. 2382
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
DEVELOPMENT OF A DIGITAL TELEREHABILITATION SOLUTION: ANALYSIS OF THE NEEDS OF PATIENTS WITH CHRONIC DISEASES
Source: International Congress 2017 – Latest insights into chronic care
Year: 2017
PSYCHOLOGICAL FACTORS PREDICTIVE OF QUALITY OF LIFE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Source: Virtual Congress 2020 – Prognosis and integrated management of COPD
Year: 2020
HEART VARIABILITY IN THE PRESENCE OF PSYCHOLOGICAL STRESS AND QUALITY OF LIFE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care
Year: 2020
PSYCHOLOGICAL FACTORS PREDICTIVE OF QUALITY OF LIFE IN PATIENTS WITH INTERSTITIAL PULMONARY DISEASE
Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis
Year: 2020
QUALITY OF LIFE IN SMOKERS FOLLOWING SMOKING CESSATION TREATMENT
Source: International Congress 2017 – Smoking cessation
Year: 2017
ASSOCIATION OF EXERCISE CAPACITY AND ENDOTHELIAL FUNCTION IN PATIENTS WITH FIBROSING INTERSTITIAL LUNG DISEASE
Source: Virtual Congress 2021 – Peripheral muscle function, exercise capacity and functional status in respiratory disease
Year: 2021
ONE YEAR MORTALITY IN PATIENTS WITH PNEUMOCOCCAL BACTERAEMIC COMMUNITY ACQUIRED PNEUMONIA: ROLE OF THREE PNEUMONIA SEVERITY SCORES
Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers
Year: 2017
A RESPIRATORY TELEREHABILITATION PROGRAM AS MAINTENANCE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Source: International Congress 2018 – Let’s interact and discuss the hot topics in pulmonary rehabilitation
Year: 2018
THE IMPACT OF PULMONARY REHABILITATION ON PHYSICAL ACTIVITY AND PHYSICAL FITNESS LEVELS IN LUNG TRANSPLANT CANDIDATES; PRELIMINARY STUDY RESULTS
Source: International Congress 2017 – Latest insights into functional capacity, muscle weakness and physical activity in chronic lung diseases
Year: 2017
QUALITY OF LIFE OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND THEIR CAREGIVERS
Source: Virtual Congress 2020 – Organising respiratory disease management in primary care
Year: 2020
RELATIONSHIP BETWEEN SIX-MINUTE WALK DISTANCE, PULMONARY FUNCTIONS AND PATIENT CENTERED OUTCOMES IN PATIENTS WITH PULMONARY HYPERTENSION
Source: International Congress 2018 – Pulmonary rehabilitation: exercise training, body composition, physical activity and other aspects
Year: 2018
MULTIDISCIPLINARY APPROACH IN THE EVALUATION AND MANAGEMENT OF PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA. A SINGLE CENTER EXPERIENCE.
Source: Virtual Congress 2020 – Novel directions in pleural disease: bench to bedside
Year: 2020
INSPIRATORY MUSCLE TRAINING BASED ON THE ANAEROBIOSIS THRESHOLD ON THE FUNCTIONAL CAPACITY OF PATIENTS SUBMITTED TO CORONARY ARTERIAL BYPASS GRAFTING: RANDOMIZED AND CONTROLLED CLINICAL TRIAL
Source: International Congress 2019 – Cardiopulmonary exercise testing
Year: 2019
CARDIOPULMONARY EXERCISE TESTING PREDICTING POSTOPERATIVE MORBIDITY IN PATIENTS WITH PULMONARY RESECTION
Source: Virtual Congress 2020 – Advances in lung function practice
Year: 2020
EVALUATION OF RESPIRATORY IMPEDANCE AND VENTILATORY HOMOGENEITY IN PATIENTS WITH PRETERM BIRTH
Source: International Congress 2018 – Paediatric bronchology
Year: 2018
IMPACT OF NON-INVASIVE VENTILATION IMMEDIATELY AFTER EXTUBATION ON CLINICAL AND FUNCTIONAL OUTCOMES IN PATIENTS SUBMITTED TO CORONARY ARTERY BYPASS GRAFTING: CLINICAL TRIAL
Source: Virtual Congress 2021 – An update on respiratory physiotherapy and respiratory muscle function and training
Year: 2021
PREDICTOR FACTORS TO POOR ADHERENCE TO ANTI-TUBERCULOSIS TREATMENT
Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis
Year: 2021
SLEEP APNOEA AS AN INDEPENDENT RISK FACTOR FOR CARDIOVASCULAR DISEASE: CURRENT EVIDENCE, BASIC MECHANISMS AND RESEARCH PRIORITIES.
Source: Eur Respir J 2007; 29: 614
Year: 2007
PULMONARY HYPERTENSION IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS ON ANTI-FIBROTIC TREATMENT WITH PIRFENIDONE OR NINTEDANIB: CLINICAL EVALUATION AND PROGNOSTIC IMPACT
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021
DIAGNOSTICS, THERAPY, COURSE AND RESULTS IN PATIENTS WITH CHRONIC EXTRINSIC ALLERGIC ALVEOLITIS.
Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept